Allyx Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Probe Substrates (NCT06632990) | Allyx Therapeutics | 2024-11-04 |
| A Study to Assess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson's (NCT06309147) | Allyx Therapeutics | 2024-03-15 |
| A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease (NCT05804383) | Allyx Therapeutics | 2023-03-28 |
| Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers (NCT05817643) | Allyx Therapeutics | 2023-01-10 |
Track Allyx Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.